Androgens regulate prostate cancer cell growth via an AMPK-PGC-1α-mediated metabolic switch JB Tennakoon, Y Shi, JJ Han, E Tsouko, MA White, AR Burns, A Zhang, ... Oncogene 33 (45), 5251-61, 2014 | 238 | 2014 |
Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction RM Kanashiro-Takeuchi, K Tziomalos, LM Takeuchi, AV Treuer, ... Proceedings of the National Academy of Sciences 107 (6), 2604-2609, 2010 | 126 | 2010 |
LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia FG Rick, AV Schally, NL Block, G Halmos, R Perez, JB Fernandez, ... The Prostate 71 (7), 736-747, 2011 | 88 | 2011 |
Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia FG Rick, AV Schally, NL Block, M Nadji, K Szepeshazi, M Zarandi, ... Proceedings of the National Academy of Sciences 108 (9), 3755-3760, 2011 | 86 | 2011 |
The potential role of follicle-stimulating hormone in the cardiovascular, metabolic, skeletal, and cognitive effects associated with androgen deprivation therapy ED Crawford, AV Schally, JH Pinthus, NL Block, FG Rick, MB Garnick, ... Urologic Oncology: Seminars and Original Investigations 35 (5), 183-191, 2017 | 83 | 2017 |
Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases FG Rick, AV Schally, L Szalontay, NL Block, K Szepeshazi, M Nadji, ... Proceedings of the National Academy of Sciences 109 (5), 1655-1660, 2012 | 75 | 2012 |
Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities R Cai, AV Schally, T Cui, L Szalontay, G Halmos, W Sha, M Kovacs, ... Peptides 52, 104-112, 2014 | 72 | 2014 |
Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI) RM Kanashiro-Takeuchi, LM Takeuchi, FG Rick, R Dulce, AV Treuer, ... Proceedings of the National Academy of Sciences 109 (2), 559-563, 2012 | 65 | 2012 |
Agonist of growth hormone-releasing hormone reduces pneumolysin-induced pulmonary permeability edema R Lucas, S Sridhar, FG Rick, B Gorshkov, NS Umapathy, G Yang, ... Proceedings of the National Academy of Sciences 109 (6), 2084-2089, 2012 | 64 | 2012 |
Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125 S Seitz, S Buchholz, AV Schally, F Weber, M Klinkhammer-Schalke, ... BMC cancer 14 (1), 847, 2014 | 62 | 2014 |
An update on the use of degarelix in the treatment of advanced hormone-dependent prostate cancer FG Rick, NL Block, AV Schally Onco Targets Ther 6, 391-402, 2013 | 58 | 2013 |
GHRH antagonist causes DNA damage leading to p21 mediated cell cycle arrest and apoptosis in human colon cancer cells F Hohla, S Buchholz, AV Schally, S Seitz, FG Rick, L Szalontay, JL Varga, ... Cell Cycle 8 (19), 3149-3156, 2009 | 57 | 2009 |
Triple-negative breast cancers express receptors for luteinizing hormone-releasing hormone (LHRH) and respond to LHRH antagonist cetrorelix with growth inhibition S Buchholz, S Seitz, AV Schally, JB Engel, FG Rick, L Szalontay, F Hohla, ... International journal of oncology 35 (4), 789-796, 2009 | 56 | 2009 |
Targeted therapy in advanced metastatic colorectal cancer: Current concepts and perspectives F Hohla, T Winder, R Greil, FG Rick, NL Block, AV Schally World Journal of Gastroenterology 20 (20), 6102-6112, 2014 | 51 | 2014 |
Discovery of LHRH and development of LHRH analogs for prostate cancer treatment AV Schally, NL Block, FG Rick The Prostate 77 (9), 1036-1054, 2017 | 49 | 2017 |
Synthesis and structure-activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth M Zarandi, R Cai, M Kovacs, P Popovics, L Szalontay, T Cui, W Sha, ... Peptides 89, 60-70, 2017 | 49 | 2017 |
Preclinical efficacy of growth hormone-releasing hormone antagonists for androgen-dependent and castration-resistant human prostate cancer CD Fahrenholtz, FG Rick, MI Garcia, M Zarandi, RZ Cai, NL Block, ... Proceedings of the National Academy of Sciences 111 (3), 1084-1089, 2014 | 48 | 2014 |
Antagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancers R Perez, AV Schally, I Vidaurre, R Rincon, NL Block, FG Rick Oncotarget 3 (9), 988-997, 2012 | 47 | 2012 |
Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist FG Rick, A Abi-Chaker, L Szalontay, R Perez, M Jaszberenyi, ... Proceedings of the National Academy of Sciences 110 (7), 2617-2622, 2013 | 46 | 2013 |
Combining Growth Hormone-Releasing Hormone Antagonist With Luteinizing Hormone-Releasing Hormone Antagonist Greatly Augments Benign Prostatic Hyperplasia Shrinkage FG Rick, L Szalontay, AV Schally, NL Block, M Nadji, K Szepeshazi, ... The Journal of Urology 187 (4), 1498-1504, 2012 | 46 | 2012 |